Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is…
| Price | $1.15 |
|---|---|
| Market cap | $51.89M |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Exchange | NASDAQ |
| 52-week range | 1.09-4.94 |
| Beta | 1.44 |
Explore RPID's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.